| (Values in U.S. Thousands) | Mar, 2024 | Mar, 2023 | Mar, 2024 | Mar, 2026 | Mar, 2026 |
| Sales | 10,091 | 21,149 | 0 | 0 | 0 |
| Sales Growth | -52.29% | unch | unch | unch | unch |
| Net Income | -52,690 | 1,166 | 0 | 0 | 0 |
| Net Income Growth | -4,618.87% | unch | unch | unch | unch |
Syncona Limited (SYNC.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Syncona Ltd is a closed-ended investment company in the United Kingdom. Its investment objective is to achieve superior long-term capital appreciation from its investments. The company invests in life science businesses (including private and quoted companies) and single or multi-asset projects (Life Science Investments).
Fiscal Year End Date: 03/31